Home Based Monitoring of Kidney Transplants Utilizing Capillary Microsamples

Launched by OSLO UNIVERSITY HOSPITAL · Apr 28, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at how kidney transplant patients can be monitored at home instead of having to visit the hospital for all their follow-up appointments after surgery. After the first couple of weeks post-transplant, participants will be randomly chosen to either continue with standard care at the hospital or to manage some of their check-ups from home. Those in the home monitoring group will take a small blood sample from a finger prick, send it to the lab, and then receive a phone call from their transplant doctor the same day to discuss the results. The goal is to see if this home-based monitoring works just as well as traditional hospital visits.

To be eligible for this trial, participants must be adults over 18 who have received a kidney transplant, are on specific medications to prevent rejection, and are considered to have a standard level of immunological risk. However, pregnant women and those currently experiencing rejection episodes cannot participate. The trial is currently recruiting patients at the Oslo University Hospital-Rikshospitalet transplant center, and it aims to provide more flexible and convenient care for kidney transplant recipients while ensuring that they continue to receive the necessary medical attention.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Kidney only transplant
• • Immunosuppressive therapy With at least one of; tacrolimus, cyclosporine, everolimus, sirolimus, mycophenolate
• • Standard immunological risk; no DSA, no PRA, not ABO-incompatible transplant
• • Age above 18 years
• • Followed at Oslo University Hospital-Rikshospitalet transplant center
• • Written informed consent
• Exclusion Criteria:
• • Pregnant or breast feeding female recipients
• • Ongoing acute rejection episodes at time of inclusion